Article | April 5, 2023

Remote Clinical Trial Monitoring: CRA Success In An Era Of Autonomy

By: Danielle Starke, inSeption Group

GettyImages-864483394 study data

Remote work became a staple of clinical trials during the COVID-19 pandemic, prompting pharmaceutical sponsors, CROs, and other service providers to refine how they conduct such trials. This shift has been most prevalent in the use of traveling HCPs (who provide care off-site), as well as more widespread use of technologies and tools supporting those individuals’ remote work.

However, remote work also has emerged as a viable option for clinical research associates (CRAs) — a position typically associated with frequent travel to be onsite. As organizations have become more skillful in training and monitoring CRAs, the latter can be empowered to enjoy greater flexibility and freedom in terms of scheduling and travel while remaining accountable (ensuring remote work options do not compromise data quality or project timelines).

Maintaining talent is a key industry challenge and a company reputed to offer lots of flexibility and autonomy, while keeping its clients happy, is an attractive place to work. That concept is rare, but incoming generations of workers have come to expect some level of work/life balance accommodations. They will not be doing less work or have diminished quality expectations placed on them, but they will be freer to perform tasks on their own time and in their own way.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene